LobbyingAmag Pharmaceuticals lobbying by quarter
Amag Pharmaceuticals's latest lobbying report covers Q4 2022, at $65K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Amag Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $65K | 2 |
| Q1 2023 | $0 | 0 |
| Q2 2023 | $0 | 0 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$65K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Farragut Partners | $50K | 1 quarters |
| Zirkelbach Strategies | $15K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DYLAN MOORE | Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10) | Q4 2022 |
| EDWARD WHITFIELD | U.S. Representative (21 yrs.) | Q4 2022 |
| JEFFERY C. MORTIER | Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes | Q4 2022 |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (RTexas) | Q4 2022 |
| KRISTEN BAUTZ | Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz | Q4 2022 |
| SARAH WALTER | Former Legislative Director/Chief Counsel, Sen. John Breaux | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/01/30for Q4 2022 | Zirkelbach Strategies | $15K |
| 23/01/20for Q4 2022 | Farragut Partners | $50K |